Febrifugine has long been applied as an anti-parasitic agent, and the realization of its activity (as HF) as an anti-autoimmune response inhibitor suggests that aaRS inhibitors may be developed into therapeutic agents to treat human disease. Here, AARS1 is linked to hydrops fetalis.